StockNews.AI
XPOF
StockNews.AI
124 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Xponential Fitness, Inc. - XPOF

1. Pomerantz LLP investigates claims against XPOF for potential securities fraud. 2. XPOF reported a fourth quarter loss and a 7.7% revenue decline. 3. The company's financial statements from 2023 will be restated. 4. XPOF's stock fell 38.45% to $7.46 following the news.

3m saved
Insight
Article

FAQ

Why Very Bearish?

XPOF's significant stock price drop reflects investor distrust following financial mismanagement. Historical examples show that restatement of financials often leads to prolonged negative sentiment.

How important is it?

The investigation suggests severe mismanagement, which could impact shareholder trust and future earnings. Legal actions could result in penalties or a drop in investor confidence.

Why Short Term?

In the short term, investor reactions and potential legal outcomes will heavily influence stock prices. Immediate market reactions after financial restatements can be severe, as seen in past cases.

Related Companies

SPCESBUXLYFT
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Xponential Fitness, Inc. (“Xponential” or the “Company”) (NYSE: XPOF).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Xponential and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On March 13, 2025, Xponential issued a press release announcing the Company’s fourth quarter and full year financial results. Among other items, Xponential reported an unexpected loss for the fourth quarter, as well as a 7.7% year-over-year revenue decline. The press release also announced that Xponential’s Board of Directors had “determined that the Company’s financial statements for its fiscal year ended December 31, 2023 should be restated.” Following these announcements, Xponential’s stock price fell $4.66 per share, or 38.45%, to close at $7.46 per share on March 14, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.    CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News